WallStreetZenWallStreetZen

NASDAQ: EOLS
Evolus Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Evolus earnings were -$43.4M for the trailing 12 months ending Mar 31, 2026, with N/A growth year over year. The latest EOLS earnings report on Mar 31, 2026 announced Q1 2026 earnings of -$10.7M, down 8,310.8% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, EOLS reported annual earnings of -$51.6M, with 2.4% growth. The next EOLS earnings date is May 12, 2026.

EOLS earnings history

Current Revenue
$301.8M
Current Earnings
-$43.4M
Current Profit Margin
-14.4%

EOLS Return on Equity

Current Company
N/A
Current Industry
18.3%
Current Market
5.2%

EOLS Return on Assets

Current Company
-19.4%
Current Industry
7.7%
EOLS is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when EOLS announces earnings.

EOLS Return on Capital Employed

Current Company
-15.27%
Current Industry
15.3%
EOLS has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

EOLS vs Pharmaceutical Stocks

TickerEBITDAEarningsY/Y EarningsEPS
EOLS-$13.70M-$43.42MN/A-$0.67
CGC-$207.31M-$236.65MN/A-$1.36
EBS$153.00M-$8.60MN/A-$0.14
KMDA$39.25M$20.20M-2.14%$0.35
SIGA$27.49M$20.23M-18.77%$0.29
View Top Pharmaceutical Stocks

EOLS earnings dates

Next earnings date
May 12, 2026

Evolus Earnings Reports & History FAQ

What were Evolus's earnings last quarter?

On EOLS's earnings call on Invalid Date, Evolus (NASDAQ: EOLS) reported Q1 2026 earnings per share (EPS) of -$0.16, up 46.67% year over year. Total EOLS earnings for the quarter were -$10.67 million. In the same quarter last year, Evolus's earnings per share (EPS) was -$0.30.

If you're new to stock investing, here's how to buy Evolus stock.

When does Evolus report earnings?

The next EOLS earnings date is Invalid Date. Add EOLS to your watchlist to be reminded of Evolus's next earnings date.

Is Evolus profitable or losing money?

As of the last Evolus earnings report, Evolus is currently losing money. Evolus's net profit (also called net income) for the twelve months ending Mar 31, 2026 was -$43.42 million, a 22.74% decrease year over year.

What was EOLS's earnings growth in the past year?

As of Evolus's earnings date in Invalid Date, Evolus's earnings has grown year over year. EOLS earnings in the past year totalled -$43.42 million.

What are Evolus's earnings expectations?

The current EPS estimate for Evolus's earnings report in Invalid Date is -$0.12.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.